市場調查報告書
商品編碼
1452594
北美家禽診斷市場預測至 2030 年 - 區域分析 - 按測試類型和疾病(禽沙門氏菌病、禽流感、新城疫、禽支原體病、傳染性支氣管炎等)North America Poultry Diagnostic Market Forecast to 2030 - Regional Analysis - By Test Type and Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others) |
北美家禽診斷市場預計將從2022年的1.1889億美元成長到2030年的2.5367億美元。預計2022年至2030年CAGR為9.9%。
農場現場診斷家禽平台推動北美家禽診斷市場
如今,在感染率較高的農場現場安裝了簡單的農場端分子診斷平台和補充監測軟體,透過對家禽動物進行病毒和細菌病原體檢測來遏制疾病傳播。此外,家禽產業團隊可以在短時間內成功開發出符合世界衛生組織 (WHO) 指南的攜帶式、電池供電、獨立的診斷平台,以確保這些設備可以在農場的任何地方運行,從而消除了需要實驗室結構、訓練有素的人員和附加設備。此外,該設備的成本比同類商用設備低 95%,並根據具有同等標準的黃金標準設備進行了驗證。因此,實施此類農場家禽疾病診斷平台將有助於農民透過早期發現和遏制來控制傳染病、抗菌素抗藥性(AMR)和人畜共通病原體的傳播。
北美洲家禽診斷市場概況
北美家禽診斷市場分為美國、加拿大和墨西哥。 2022年,美國在該地區佔據最大的市場佔有率,並且由於家禽衍生產品的消費不斷增加以及消費者食品安全意識不斷增強,預計在預測期內將繼續保持主導地位。此外,根據聯合國糧食及農業組織(UNFAO)公佈的統計數據,2022年北美雞蛋和母雞產量均增加。
北美家禽診斷市場收入及 2030 年預測(百萬美元)
北美家禽診斷市場細分
北美家禽診斷市場分為測試類型、疾病和國家。
根據測試類型,北美家禽診斷市場分為酵素連結免疫吸附測定(ELISA)測試、聚合酶鏈反應(PCR)測試、血凝抑制(hi)測試等。 2022 年,酶聯免疫吸附測定 (ELISA) 測試領域佔據北美家禽診斷市場的最大佔有率。
根據疾病,北美洲家禽診斷市場分為禽流感、傳染性支氣管炎、禽沙門氏菌病、新城疫、禽支原體病等。 2022 年,禽流感細分市場佔據北美家禽診斷市場的最大佔有率。
根據國家/地區,北美家禽診斷市場分為美國、加拿大和墨西哥。 2022 年,美國將主導北美家禽診斷市場。
Thermo Fisher Scientific Inc、Idex Laboratories Inc、Qiagen NV、Eurofins Scientific SE、Boehringer Ingelheim International GmbH、Zoetis Inc、BioCheck BV 和 Bioneer Corp 是北美家禽診斷市場上的一些領先公司。
The North America poultry diagnostic market is expected to grow from US$ 118.89 million in 2022 to US$ 253.67 million by 2030. It is estimated to grow at a CAGR of 9.9% from 2022 to 2030.
Farm-Side Diagnostic Poultry Platform Fuel North America Poultry Diagnostic Market
Nowadays, a simple farm-side molecular diagnostic platform and complementary surveillance software are installed at the farm site with a high infection rate to curb the spread of disease by test poultry animals for viral and bacterial pathogens. Also, within a short span the poultry industry team can successfully develop a portable, battery-powered, stand-alone diagnostic platform abiding by World Health Organization (WHO) guidelines to ensure that these devices can be operated anywhere on the farm, eliminating the need for laboratory structure, trained personnel, and additional equipment. Also, the cost of the device is 95% lower than comparable commercially available devices and validated against gold standard devices showing equivalent standards. Therefore, implementation of such farm-side poultry disease diagnostic platforms would help farmers keep a check on the spread of infectious disease, antimicrobial resistance (AMR), and zoonotic pathogens by enabling early detection and containment.
North America Poultry Diagnostic Market Overview
The North America poultry diagnostics market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share in this region and is expected to continue its dominance during the forecast period due to the increasing consumption of poultry-derived products and growing consumer awareness regarding food safety. Moreover, as per the statistics published by the United Nations Food and Agriculture Organization (UNFAO), in 2022, there was an increase in the production of eggs and hens in North America.
North America Poultry Diagnostic Market Revenue and Forecast to 2030 (US$ Million)
North America poultry diagnostic market Segmentation
The North America poultry diagnostic market is segmented into test type, disease, and country.
Based on test type, the North America poultry diagnostic market is segmented into enzyme-linked immunosorbent assay (ELISA) tests, polymerase chain reaction (PCR) tests, hemagglutination-inhibition (hi), and others. The enzyme-linked immunosorbent assay (ELISA) tests segment held the largest share of the North America poultry diagnostic market in 2022.
Based on disease, the North America poultry diagnostic market is segmented into avian influenza, infectious bronchitis, avian salmonellosis, Newcastle disease, avian mycoplasmosis, and others. The avian influenza segment held the largest share of the North America poultry diagnostic market in 2022.
Based on country, the North America poultry diagnostic market is segmented into the US, Canada, and Mexico. The US dominated the North America poultry diagnostic market in 2022.
Thermo Fisher Scientific Inc, Idexx Laboratories Inc, Qiagen NV, Eurofins Scientific SE, Boehringer Ingelheim International GmbH, Zoetis Inc, BioCheck BV, and Bioneer Corp are some of the leading companies operating in the North America poultry diagnostic market.